Saturday, September 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleSeeking Alpha· March 15, 2026

Earnings week ahead: FDX, BABA, XPEV, MU, GIS, DOCU, OKLO, ACN, and more

View original at seekingalpha.com
Earnings week ahead: FDX, BABA, XPEV, MU, GIS, DOCU, OKLO, ACN, and more [Quarterly Report Financial Analysis and Business Performance Review with Office Tools] Mohamad Faizal Bin Ramli/iStock via Getty Images Wall Street has entered a quieter phase of the earnings calendar, but the macro environment is shouting…
Opening lines of the source · Seeking Alpha · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Micron has likely secured early HBM4 orders

    60% confidence
  • Alibaba rated Sell, citing heavy reliance on China's domestic economy and ongoing macro and geopolitical uncertainties that could weigh on long-term growth

    60% confidence
  • Samsung Electronics's HBM4 production ramp could pressure Micron's market share

    60% confidence
  • Alibaba named as top pick among Chinese tech companies, maintaining an Overweight rating and calling it a potential global AI winner

    60% confidence
  • Memory cycle to remain robust, forecasting DRAM contract prices to jump about 100% in Q1 2026, followed by more than 30% sequential growth in Q2

    60% confidence
  • Alibaba expected to beat conservative Q3 estimates and provide upbeat commentary, supported by cloud growth, improving quick-commerce margins, and strong user retention. Price target set at $153.51, implying about 15-16% upside

    60% confidence
  • Micron Q2 revenue projected at $23B with 77% gross margins, and Q3 revenue potentially reaching $29B with margins expanding further

    60% confidence
  • Dollar Tree is likely to post solid Q4 earnings supported by strong sales momentum and holiday-season assortments. Fair value for DLTR estimated at about $134.80 per share

    60% confidence
  • DocuSign's valuation has compressed significantly despite steady revenue growth and improving free cash flow. AI disruption concerns may be overstated, as digital agreement infrastructure remains deeply embedded in enterprise software ecosystems

    60% confidence
  • XPeng's performance since the second half of 2024 supports its competitive positioning. Additional upside from emerging businesses such as AeroHT, robotaxis, and humanoid robotics, which could add about $7B in enterprise value. Price target of $25.50 for XPEV

    60% confidence
  • Micron may need consistent beat-and-raise quarters to sustain momentum after a 215% rally since last summer

    60% confidence
  • DocuSign is experimenting with a potential 50% price increase for eSignature Professional tier while raising the annual envelope limit from 100 to unlimited

    60% confidence
  • Management confirmed pricing tests are underway but noted that no final decisions have been made

    60% confidence
  • Expanding international adoption and growth in the IAM platform could provide new revenue streams beyond core e-signature services

    60% confidence
  • The pricing test impact is difficult to quantify due to limited data, though the initiative could support growth in FY2027 and FY2028

    60% confidence
  • Strong fiscal Q1 results with $13.6B revenue, 56.8% gross margin, $4.78 EPS, and a record $3.9B in free cash flow. AI-driven demand has tightened supply, with HBM capacity sold out through 2026

    60% confidence
  • Micron price target raised to $430 from $385, citing rising memory prices and robust AI demand

    60% confidence
  • Micron price target lifted to $525 from $345 while maintaining a positive rating

    60% confidence
  • Positive remarks after testing XPeng's VLA 2.0 autonomous driving system in Guangzhou

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com